article thumbnail

Ismail El-Hamamsy, MD, PhD, Named President of the Heart Valve Society

DAIC

Griepp , MD Professor in Cardiovascular Surgery at the Icahn School of Medicine at Mount Sinai , was named as the new President of the Heart Valve Society ( HVS ) at the 2024 HVS Annual Meeting on Wednesday, February 21, in Boston.

article thumbnail

Artificial intelligence in heart valve disease: diagnosis, innovation and treatment. A state-of-the-art review

The British Journal of Cardiology

In recent years, artificial intelligence (AI) has been used to improve the precision of valvular heart disease diagnosis and treatment. It has the ability to identify and risk stratify patients with valvular heart disease and holds promise in improving the innovation of new treatments through shorter, safer and more effective clinical trials.

article thumbnail

Heart Valve Disease Forum 2023

Society of Thoracic Surgeons - Allied Health

This year, session topics will explore academic and systematic considerations on the basics of the aortic valve to the latest trends, various surgical methods, and treatments employing experts from various fields. There will also be an in-depth discussion on the lifelong management of aortic valve surgery patients.

article thumbnail

Atrium Health Sanger Heart & Vascular Institute Performs Landmark Heart Valve Surgery

DAIC

Michael Rinaldi , an interventional cardiologist and the medical director of the structural heart program at Atrium Health Sanger Heart & Vascular Institute. "We We have been eagerly anticipating the opportunity to bring this innovative technology to our community.

article thumbnail

Autus Valve | The expandable artificial heart valve

Wellnest

In such scenarios, cardiologists’ primary form of treatment for children with coronary heart disease is a heart valve implant. Unfortunately, the traditional pulmonary valves have a fixed diameter that can’t match the size of the child’s heart over time.

article thumbnail

Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix

DAIC

mtaschetta-millane Mon, 07/29/2024 - 09:02 July 29, 2024 — Edwards Lifesciences announced investments that reflect the company’s deep commitment to advancing patient care through structural heart innovation, addressing large unmet patient needs and supporting sustainable long-term growth.

article thumbnail

Direct aortic TAVI via anterior right mini-thoracotomy using 32 mm myval for pure aortic regurgitation

Journal of Cardiothoracic Surgery

The patient underwent a successful TAVI procedure using the XL-Myval 32 mm transcatheter heart valve (THV) via an anterior right mini-thoracotomy with a direct aortic approach. The patient recovered well post-operatively with good hemodynamic resolution.

Aortic 52